These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29351622)

  • 41. Resistance against antimicrobial peptides is independent of Escherichia coli AcrAB, Pseudomonas aeruginosa MexAB and Staphylococcus aureus NorA efflux pumps.
    Rieg S; Huth A; Kalbacher H; Kern WV
    Int J Antimicrob Agents; 2009 Feb; 33(2):174-6. PubMed ID: 18945595
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synergistic microbicidal effect of cationic antimicrobial peptides and teicoplanin against planktonic and biofilm-encased Staphylococcus aureus.
    Koppen BC; Mulder PPG; de Boer L; Riool M; Drijfhout JW; Zaat SAJ
    Int J Antimicrob Agents; 2019 Feb; 53(2):143-151. PubMed ID: 30315918
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antimicrobial and biophysical properties of surfactant supplemented with an antimicrobial peptide for treatment of bacterial pneumonia.
    Banaschewski BJ; Veldhuizen EJ; Keating E; Haagsman HP; Zuo YY; Yamashita CM; Veldhuizen RA
    Antimicrob Agents Chemother; 2015; 59(6):3075-83. PubMed ID: 25753641
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bacitracin and nisin resistance in Staphylococcus aureus: a novel pathway involving the BraS/BraR two-component system (SA2417/SA2418) and both the BraD/BraE and VraD/VraE ABC transporters.
    Hiron A; Falord M; Valle J; Débarbouillé M; Msadek T
    Mol Microbiol; 2011 Aug; 81(3):602-22. PubMed ID: 21696458
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased resistance to cationic antimicrobial peptide LL-37 in methicillin-resistant strains of Staphylococcus aureus.
    Ouhara K; Komatsuzawa H; Kawai T; Nishi H; Fujiwara T; Fujiue Y; Kuwabara M; Sayama K; Hashimoto K; Sugai M
    J Antimicrob Chemother; 2008 Jun; 61(6):1266-9. PubMed ID: 18367458
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of cyclotides against cutaneous infections caused by Staphylococcus aureus.
    Fensterseifer IC; Silva ON; Malik U; Ravipati AS; Novaes NR; Miranda PR; Rodrigues EA; Moreno SE; Craik DJ; Franco OL
    Peptides; 2015 Jan; 63():38-42. PubMed ID: 25451333
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Natural and synthetic cathelicidin peptides with anti-microbial and anti-biofilm activity against Staphylococcus aureus.
    Dean SN; Bishop BM; van Hoek ML
    BMC Microbiol; 2011 May; 11():114. PubMed ID: 21605457
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Very Short and Stable Lactoferricin-Derived Antimicrobial Peptides: Design Principles and Potential Uses.
    Svendsen JSM; Grant TM; Rennison D; Brimble MA; Svenson J
    Acc Chem Res; 2019 Mar; 52(3):749-759. PubMed ID: 30829472
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impairment of innate immune killing mechanisms by bacteriostatic antibiotics.
    Kristian SA; Timmer AM; Liu GY; Lauth X; Sal-Man N; Rosenfeld Y; Shai Y; Gallo RL; Nizet V
    FASEB J; 2007 Apr; 21(4):1107-16. PubMed ID: 17215486
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mechanisms and consequences of bacterial resistance to antimicrobial peptides.
    Andersson DI; Hughes D; Kubicek-Sutherland JZ
    Drug Resist Updat; 2016 May; 26():43-57. PubMed ID: 27180309
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Folic acid-modified mesoporous silica nanoparticles with pH-responsiveness loaded with Amp for an enhanced effect against anti-drug-resistant bacteria by overcoming efflux pump systems.
    Chen X; Liu Y; Lin A; Huang N; Long L; Gang Y; Liu J
    Biomater Sci; 2018 Jun; 6(7):1923-1935. PubMed ID: 29850668
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antimicrobial synergy of monolaurin lipid nanocapsules with adsorbed antimicrobial peptides against Staphylococcus aureus biofilms in vitro is absent in vivo.
    Rozenbaum RT; Su L; Umerska A; Eveillard M; Håkansson J; Mahlapuu M; Huang F; Liu J; Zhang Z; Shi L; van der Mei HC; Busscher HJ; Sharma PK
    J Control Release; 2019 Jan; 293():73-83. PubMed ID: 30465823
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Small-Molecule Inhibitor of
    Huang Y; Alumasa JN; Callaghan LT; Baugh RS; Rae CD; Keiler KC; McGillivray SM
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30917982
    [No Abstract]   [Full Text] [Related]  

  • 54. Human cathelicidin LL-37 resistance and increased daptomycin MIC in methicillin-resistant Staphylococcus aureus strain USA600 (ST45) are associated with increased mortality in a hospital setting.
    Sakoulas G; Guram K; Reyes K; Nizet V; Zervos M
    J Clin Microbiol; 2014 Jun; 52(6):2172-4. PubMed ID: 24648548
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of SecDF on the antimicrobial functions of cathelicidins against Staphylococcus aureus.
    Blodkamp S; Kadlec K; Gutsmann T; Quiblier C; Naim HY; Schwarz S; von Köckritz-Blickwede M
    Vet Microbiol; 2017 Feb; 200():52-58. PubMed ID: 27062479
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The GraRS regulatory system controls Staphylococcus aureus susceptibility to antimicrobial host defenses.
    Kraus D; Herbert S; Kristian SA; Khosravi A; Nizet V; Götz F; Peschel A
    BMC Microbiol; 2008 Jun; 8():85. PubMed ID: 18518949
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sap transporter mediated import and subsequent degradation of antimicrobial peptides in Haemophilus.
    Shelton CL; Raffel FK; Beatty WL; Johnson SM; Mason KM
    PLoS Pathog; 2011 Nov; 7(11):e1002360. PubMed ID: 22072973
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antimicrobial Activity and Stability of Short and Long Based Arachnid Synthetic Peptides in the Presence of Commercial Antibiotics.
    Arenas I; Villegas E; Walls O; Barrios H; Rodríguez R; Corzo G
    Molecules; 2016 Feb; 21(2):. PubMed ID: 26901176
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The novel antimicrobial peptide PXL150 in the local treatment of skin and soft tissue infections.
    Myhrman E; Håkansson J; Lindgren K; Björn C; Sjöstrand V; Mahlapuu M
    Appl Microbiol Biotechnol; 2013 Apr; 97(7):3085-96. PubMed ID: 23053090
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interaction of the GraRS two-component system with the VraFG ABC transporter to support vancomycin-intermediate resistance in Staphylococcus aureus.
    Meehl M; Herbert S; Götz F; Cheung A
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2679-89. PubMed ID: 17502406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.